A transgenic mouse expressing human CYP1A2 in the pancreas

被引:7
作者
Ueno, T
Tamura, S
Frels, WI
Shou, M
Gonzalez, FJ
Kimura, S
机构
[1] NCI, Lab Metab, Bethesda, MD 20892 USA
[2] NCI, Mol Carcinogenesis Lab, Bethesda, MD 20892 USA
[3] BioQUAL Inc, Rockville, MD 20850 USA
关键词
CYP1A2; transgenic mouse; pancreas; estrone hydroxylation;
D O I
10.1016/S0006-2952(00)00389-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A transgenic mouse line expressing the human cytochrome P450 CYP1A2 in the pancreas under the control of the mouse elastase promoter was established. The expression of CYP1A2 was specific to the transgenic pancreas and was not found in the control wild-type mouse pancreas. The level of CYP1A2 expressed in pancreatic microsomes from transgenic mice was comparable to that of the endogenously expressed CYP1A2 protein in the liver, as judged by western blotting analyses. Estrone metabolism was used to determine the activity of CYP1A2 expressed in the pancreas of the transgenic mouse. The transgenic pancreas exhibited almost one-third to one half of the activity of wild-type or CYP1A2 transgenic mouse liver, whereas the wild-type pancreas demonstrated no activity. The addition of NADPH-cytochrome P450 oxidoreductase to the reaction mixture containing pancreatic microsomes from the transgenic mice did not increase the estrone metabolism activity significantly. This transgenic mouse line provides another useful tool to study human CYP1A2 and its relation to chemical toxicity and carcinogenesis. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:857 / 863
页数:7
相关论文
共 28 条
[1]   Metabolic activation of aromatic amines by human pancreas [J].
Anderson, KE ;
Hammons, GJ ;
Kadlubar, FF ;
Potter, JD ;
Kaderlik, KR ;
Ilett, KF ;
Minchin, RF ;
Teitel, CH ;
Chou, HC ;
Martin, MV ;
Guengerich, FP ;
Barone, GW ;
Lang, NP ;
Peterson, LA .
CARCINOGENESIS, 1997, 18 (05) :1085-1092
[2]  
[Anonymous], 1994, MANIPULATING MOUSE E
[3]   MUTAGEN ACTIVATION BY CDNA-EXPRESSED P1450, P3450, AND P450A [J].
AOYAMA, T ;
GONZALEZ, FJ ;
GELBOIN, HV .
MOLECULAR CARCINOGENESIS, 1989, 1 (04) :253-259
[4]   DIFFERENTIAL TISSUE-SPECIFIC EXPRESSION AND INDUCTION OF CYTOCHROME-P450IVA1 AND ACYL-COA OXIDASE [J].
BELL, DR ;
BARS, RG ;
ELCOMBE, CR .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 206 (03) :979-986
[5]   ROLE OF CYTOCHROME P4501A2 IN CHEMICAL CARCINOGENESIS - IMPLICATIONS FOR HUMAN VARIABILITY IN EXPRESSION AND ENZYME-ACTIVITY [J].
EATON, DL ;
GALLAGHER, EP ;
BAMMLER, TK ;
KUNZE, KL .
PHARMACOGENETICS, 1995, 5 (05) :259-274
[6]  
Estabrook RW, 1996, CYTOCHROMES P450 MET, P3
[7]   EVOLUTION OF THE P450-GENE SUPERFAMILY - ANIMAL PLANT WARFARE, MOLECULAR DRIVE AND HUMAN GENETIC-DIFFERENCES IN DRUG OXIDATION [J].
GONZALEZ, FJ ;
NEBERT, DW .
TRENDS IN GENETICS, 1990, 6 (06) :182-186
[8]  
Guengerich F P, 1995, Princess Takamatsu Symp, V23, P78
[9]   Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species [J].
Guengerich, FP .
CHEMICO-BIOLOGICAL INTERACTIONS, 1997, 106 (03) :161-182
[10]  
HALL PD, 1989, CARCINOGENESIS, V10, P521